Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system

Molecular Pharmacology

Volumn 49, Issue 4, 1996, Pages 707-714

  Pan, Xianghua ^a   Ikeda, Stephen R ^a   Lewis, Deborah L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CALCIUM CHANNEL; CANNABINOID RECEPTOR; CANNABIS; CONOTOXIN; ION CHANNEL; PERTUSSIS TOXIN;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; DRUG EFFECT; EFFECTOR CELL; GENE EXPRESSION; NERVE CELL MEMBRANE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SUPERIOR CERVICAL GANGLION; TARGET CELL;

ANIMALS; ARACHIDONIC ACIDS; BRAIN; CALCIUM CHANNELS; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; MORPHOLINES; NAPHTHALENES; OMEGA-CONOTOXIN GVIA; PEPTIDES; PERTUSSIS TOXIN; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SUPERIOR CERVICAL GANGLION; VIRULENCE FACTORS, BORDETELLA;

EID: 0029872234     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dewey, W. L. Cannabinoid pharmacology. Pharmacol. Rev. 38:2:151-178 (1986).
2. Hollister, L. E Health aspects of cannabis. Pharmacol. Rev. 38:1:1-20 (1986).
3. Devane, W. A., F. A. I. Dysarz, M. R. Johnson, L. S. Melvin, and A. C. Howlett. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:605-613 (1988).
4. Herkenham, M , A. B. Lynn, M. D. Little, M. R. Johnson, L. S. Melvin, B. R. de Costa, and K. C. Rice. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA 87:1932-1936 (1990).
5. Howlett, A. C., M. Bidaut-Russell, W. A. Devane, L. S. Melvin, M. R. Johnson, and M. Herkenham. The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends. Neurosci. 13:420-423 (1990).
6. D'Ambra, T. E., K. G. Estep, M. R. Bell, M. A. Eissenstat, K. A. Josef, S. J. Ward, D. A. Haycock, E. R. Baizman, F. M. Casiano, N. C. Beglin, S. M. Chippari, J. D. Grego, R. K. Kullnig, and G. T. Daley. Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor. J. Med. Chem. 35:124-135 (1992).
7. Kuster, J. E., J. I. Stevenson, S. J. Ward, T. E. D'Ambra, and D. A. Haycock. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther. 264:1352-1363 (1993).
8. Matsuda, L. A., S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond.) 346:561-564 (1990).
9. Matsuda, L. A , T. I. Bonner, and S. J. Lolait. Localization of cannabinoid receptor mRNA in rat brain, J. Camp. Neurol. 327:535-550 (1993).
10. Howlett, A. C., and R. M. Fleming. Cannabinoid inhibition of adenylate cyclase: pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. 26:532-538 (1984).
11. Devane, W. A., J. W. Spain, C. J. Coscia, and A. C. Hewlett. An assessment of the role of opioid receptors in the response to cannabimimetic drugs. J. Neurochem. 46:1929-1935 (1986).
12. Caulfield, M. P., and D. A. Brown. Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106:231-232 (1992).
13. Mackie, K., and B. Hille. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89:3825-3829 (1992).
14. Ikeda, S. R., D M. Lovinger, B. A. McCool, and D. L. Lewis. Heterologous expression of metabotropic glutamate receptors in adult rat sympathetic neurons: subtype-specific coupling to ion channels. Neuron 14:1029-1038 (1995).
15. Hille, B. Modulation of ion-channel function by G-protein-coupled receptors. Trends. Neurosci. 17:531-535 (1994).
16. Ikeda, S. R., and G G. Schofield. Somatostatin blocks a calcium current in rat sympathetic ganglion neurons. J. Physiol. 409:221-240 (1989).
17. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch. 391:85-100 (1981).
18. Bean, B. P. Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature (Lond.) 340:153-156 (1989).
19. Ikeda, S. R. Double-pulse calcium channel current facilitation in adult rat sympathetic neurons. J. Physiol. 439:181-214 (1991).
20. Kasai, H. Voltage- and time-dependent inhibition of neuronal calcium channels by a GTP-binding protein in a mammalian cell line. J. Physiol. 448:189-209 (1992).
21. Elmslie, K., and S W Jones. Concentration dependence of neurotransmitter effects on calcium current kinetics in frog sympathetic neurons. J. Physiol 481:35-46 (1994)
22. Holz, G. G. IV, S. Rane, and K. Dunlap. GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature (Lond) 319:370-672 (1986).
23. 2+ channels in supporting hippocampal synaptic transmission. Science (Washington D. C.) 264:107-111 (1994).
24. Devane, W. A., L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Washington D. C.) 258:1946-1949 (1992).
25. Mackie, K., W. A. Devane, and B. Hille. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44:498-503 (1993).
26. Deadwyler, S. A., K. E. Hampson, B. A. Bennett, T. A. Edwards, J. Mu, M. A. Pacheco, S. J. Ward, and S. R. Childers. Cannabinoids modulate potassium current in cultured hippocampal neurons. Recept. Channels 1:121-134 (1993).
27. Schofield, G. G., and S. R. Ikeda. Potassium currents of acutely isolated adult rat superior cervical ganglion neurons. Brain Res. 485:205-214 (1989).
28. Felder, C. C., J. S. Veluz, H. L. Williams, E. M. Briley, and L. A. Matsuda. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42:838-845 (1992).
29. Shen, M., T. M. Piser, and S. A. Thayer. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. Soc. Neurosci. Abstr. 21:616.7 (1995).
30. Kasai, H. Tonic inhibition and rebound facilitation of a neuronal calcium channel by a GTP-binding protein. Proc. Natl. Acad. Sci. USA 88:8855-8859 (1991).
31. Lipscombe, D , S. Kongsamut, and R. W. Tsien. alpha-Adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium-channel gating. Nature (Lond.) 340:639-642 (1989).
32. 2- channels in evoked release of norepinephrine from sympathetic neurons. Science (Washington D. C.) 239:57-60 (1988).
33. 2+ channels in mammalian central neurons. Trends. Neurosci. 18:89-98 (1995).
34. Pertwee, R. G. The central neuropharmacology of psychotropic cannabinoids. Pharmacol. Ther. 36:189-261 (1988).
35. Herkenham, M., A. B. Lynn, B. R. de Costa, and E. K. Richfield. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547:367-274 (1991).
36. Pacheco, M., S. R. Childers, R. Arnold, F. Casiano, and S. J. Ward. Aminoalkylindoles: actions on specific G-protein-linked receptors. J. Pharmacol. Exp. Ther. 257:170-183 (1991).
37. Pertwee, R. G., L. A. Stevenson, D. B. Elrick, R. Mechoulam, and A. D. Corbett. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric pelxus preparation of guinea-pig small intestine. Br. J. Pharmacol. 105:580-984 (1992).
38. Pertwee, R. G., and G. Griffin. A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens. Eur. J. Pharmacol. 272:67-72 (1995).
39. Plummer, M. R., D. E. Logothetis, and P. Hess. Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 2:1453-1463 (1989).
40. 2+ channels in adult rat sympathetic neurons. J. Neurophysiol. 70:610-620 (1993).
41. Mackie, K., Y. Lai, R. Westenbroek, and R. Mitchell. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15:6552-6561 (1995).
42. Deadwyler, S. A., R. E. Hampson, J. Mu, A. Whyte, and S. Childers. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neuron via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273:734-743 (1995).
43. Shire, D., C. Carillon, K. Mourad, B. Calandra, M. Rinaldi-Carmona, G. Le Fur, B. Capat, and P. Ferrara. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270:3726-3731 (1995).